250 related articles for article (PubMed ID: 30723901)
1. How clinically important are non-D Rh antibodies?
Healsmith S; Savoia H; Kane SC
Acta Obstet Gynecol Scand; 2019 Jul; 98(7):877-884. PubMed ID: 30723901
[TBL] [Abstract][Full Text] [Related]
2. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
[TBL] [Abstract][Full Text] [Related]
3. Impact of red blood cell alloimmunization on fetal and neonatal outcomes: A single center cohort study.
Lieberman L; Callum J; Cohen R; Cserti-Gazdewich C; Ladhani NNN; Buckstein J; Pendergrast J; Lin Y
Transfusion; 2020 Nov; 60(11):2537-2546. PubMed ID: 32893897
[TBL] [Abstract][Full Text] [Related]
4. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
[TBL] [Abstract][Full Text] [Related]
5. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
[TBL] [Abstract][Full Text] [Related]
6. [THE FETAL MIDDLE CEREBRAL ARTERY PEAK SYSTOLIC VELOCITY AS A PEDICTOR OF FETAL ANEMIA IN RH-ALLOIMMUNIZED PREGNANCY].
Markov D; Pavlova E; Atanassova D; Diavolov V; Hitrova S; Vakrilova L; Pramatarova T; Slancheva B; Ivanov S
Akush Ginekol (Sofiia); 2015; 54(4):67-72. PubMed ID: 26410952
[TBL] [Abstract][Full Text] [Related]
7. The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland.
Chandrasekar A; Morris KG; Tubman TR; Tharma S; McClelland WM
Ulster Med J; 2001 Nov; 70(2):89-94. PubMed ID: 11795772
[TBL] [Abstract][Full Text] [Related]
8. Fetal anemia due to non-Rhesus-D red-cell alloimmunization.
Moise KJ
Semin Fetal Neonatal Med; 2008 Aug; 13(4):207-14. PubMed ID: 18396474
[TBL] [Abstract][Full Text] [Related]
9. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immune globulin in the management of severe Rh D hemolytic disease.
Porter TF; Silver RM; Jackson GM; Branch DW; Scott JR
Obstet Gynecol Surv; 1997 Mar; 52(3):193-7. PubMed ID: 9061721
[TBL] [Abstract][Full Text] [Related]
11. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.
Kriplani A; Malhotra Singh B; Mandal K
Gynecol Obstet Invest; 2007; 63(3):176-80. PubMed ID: 17143009
[TBL] [Abstract][Full Text] [Related]
12. Personalized treatment with immunoadsorption and intravenous immunoglobulin in a case of severe Rh alloimmunization during pregnancy unresponsive to plasma - exchange.
Colpo A; Tison T; Gervasi MT; Vio C; Vicarioto M; De Silvestro G; Marson P
Transfus Apher Sci; 2017 Jun; 56(3):480-483. PubMed ID: 28648573
[TBL] [Abstract][Full Text] [Related]
13. Maternal CW alloimmunization.
Bowman JM; Pollock J
Vox Sang; 1993; 64(4):226-30. PubMed ID: 8517051
[TBL] [Abstract][Full Text] [Related]
14. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
Palfi M; Hildén JO; Matthiesen L; Selbing A; Berlin G
Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
[TBL] [Abstract][Full Text] [Related]
15. Reassessing critical maternal antibody threshold in RhD alloimmunization: a 16-year retrospective cohort study.
Walsh CA; Doyle B; Quigley J; McAuliffe FM; Fitzgerald J; Mahony R; Higgins S; Carroll S; McParland P
Ultrasound Obstet Gynecol; 2014 Dec; 44(6):669-73. PubMed ID: 24706487
[TBL] [Abstract][Full Text] [Related]
16. The combined effect of anti-D and non-D Rh antibodies in maternal alloimmunization.
Gedik Özköse Z; Oğlak SC
Turk J Obstet Gynecol; 2021 Sep; 18(3):181-189. PubMed ID: 34580411
[TBL] [Abstract][Full Text] [Related]
17. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden.
Gottvall T; Filbey D
Acta Obstet Gynecol Scand; 2008; 87(8):843-8. PubMed ID: 18704776
[TBL] [Abstract][Full Text] [Related]
18. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
Gudlaugsson B; Hjartardottir H; Svansdottir G; Gudmundsdottir G; Kjartansson S; Jonsson T; Gudmundsson S; Halldorsdottir AM
Transfusion; 2020 Jan; 60(1):175-183. PubMed ID: 31850521
[TBL] [Abstract][Full Text] [Related]
19. [Spontaneous antepartal RhD alloimmunization].
Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
[TBL] [Abstract][Full Text] [Related]
20. RhIg for the prevention Rh immunization and IVIg for the treatment of affected neonates.
Legler TJ
Transfus Apher Sci; 2020 Oct; 59(5):102950. PubMed ID: 33004277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
